1108 related articles for article (PubMed ID: 28229191)
61.
Bashank N; Sharef S; Mohran TZ; Khalil M
EJNMMI Rep; 2024 Apr; 8(1):8. PubMed ID: 38748324
[TBL] [Abstract][Full Text] [Related]
62. Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
Xiao-Xue W; Xinyue H; Lijun Z
Med Clin (Barc); 2020 Jan; 154(2):61-65. PubMed ID: 31757394
[TBL] [Abstract][Full Text] [Related]
63. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
[TBL] [Abstract][Full Text] [Related]
64. Prognostic value of bone marrow
Lee JW; Lee SC; Kim HJ; Lee SM
Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
[TBL] [Abstract][Full Text] [Related]
65. PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma.
Wang Y; Xie L; Tian R; Deng Y; Zhang W; Zou L; Zhang H; Liu J; Zhao S; Ding W; Liu W; Jiang M
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2529-2539. PubMed ID: 31485768
[TBL] [Abstract][Full Text] [Related]
66. Positron emission tomography in patients with Hodgkin's disease: correlation to histopathologic subtypes.
Döbert N; Menzel C; Berner U; Hamscho N; Wördehoff N; Mitrou P; Grünwald F
Cancer Biother Radiopharm; 2003 Aug; 18(4):565-71. PubMed ID: 14503951
[TBL] [Abstract][Full Text] [Related]
67. Bone marrow uptake of indolent non-Hodgkin lymphoma on PET/CT with histopathological correlation.
Lee EY; Gill H; Wang Y; Kwong YL; Khong PL
Nucl Med Commun; 2015 Oct; 36(10):1035-41. PubMed ID: 26225940
[TBL] [Abstract][Full Text] [Related]
68. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
[TBL] [Abstract][Full Text] [Related]
69. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
Adams HJ; Nievelstein RA; Kwee TC
Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
[TBL] [Abstract][Full Text] [Related]
70. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
[TBL] [Abstract][Full Text] [Related]
71. Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter.
Kand PG; Tiwari BP; Basu S; Asopa RV; Nayak UN
Indian J Cancer; 2010; 47(4):380-4. PubMed ID: 21131749
[TBL] [Abstract][Full Text] [Related]
72. Bone marrow involvement in pediatric malignancies: a comparison study of Positron emission tomographycomputed tomography and bone marrow biopsy.
Tezol Ö; Sağcan F; Özcan PP; Çıtak EÇ
Turk J Pediatr; 2020; 62(2):182-190. PubMed ID: 32419409
[TBL] [Abstract][Full Text] [Related]
73. PET/CT versus bone marrow biopsy in the initial evaluation of bone marrow infiltration in various pediatric malignancies.
Zapata CP; Cuglievan B; Zapata CM; Olavarrieta R; Raskin S; Desai K; De Angulo G
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28901637
[TBL] [Abstract][Full Text] [Related]
74. The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma.
El-Najjar I; Montoto S; McDowell A; Matthews J; Gribben J; Szyszko TA
Nucl Med Commun; 2014 Mar; 35(3):311-5. PubMed ID: 24323311
[TBL] [Abstract][Full Text] [Related]
75. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
[TBL] [Abstract][Full Text] [Related]
76. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
77. The Diagnostic Value of
Liu J; Li C; Yang X; Lu X; Zhang M; Qian L; Wang W; Kan Y; Yang J
Contrast Media Mol Imaging; 2022; 2022():7556315. PubMed ID: 35082556
[TBL] [Abstract][Full Text] [Related]
78. Usefulness of (18)F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Patients with High-Grade Non-Hodgkin's Lymphoma.
Lee Y; Hwang KH; Hong J; Park J; Lee JH; Ahn JY; Kim JH; Lee H; Kim SG; Shin JY
Nucl Med Mol Imaging; 2012 Dec; 46(4):269-77. PubMed ID: 24900074
[TBL] [Abstract][Full Text] [Related]
79. Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information.
Nakajima R; Moskowitz AJ; Michaud L; Mauguen A; Batlevi CL; Dogan A; Schöder H
Blood Adv; 2020 Apr; 4(8):1812-1823. PubMed ID: 32343798
[TBL] [Abstract][Full Text] [Related]
80. Role of 2-(fluorine-18) Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in Initial Staging and Bone Marrow Involvement Prediction in Patients with Newly Diagnosed Lymphoma in Correlation with Bone Marrow Study.
Krishna S; Ravina M; Nanda S; Lukose TT; Moideen A; Bansal H; Dasgupta S; Kote R
Indian J Nucl Med; 2024; 39(1):10-17. PubMed ID: 38817719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
